Synthesis of clasto-lactacystin beta-lactone and analogs thereof
AssigneeMillennium Pharmaceuticals, Inc.
InventorsFran.cedilla.ois Soucy, Louis Plamondon, Mark Behnke, William Roush
Life of this patent
Estimating the term…
Abstract
The present invention is directed to an improved synthesis of clasto-lactacystin-.beta.-lactone, and analogs thereof, that proceeds in fewer steps and in much greater overall yield than syntheses described in the prior art. The synthetic pathway relies upon a novel stereospecific synthesis of an oxazoline intermediate and a unique stereoselective addition of a formyl amide to the oxazoline. Also described are novel clasto-lactacystin-.beta.-lactones, and analogs thereof and their use as proteosome inhibitors.
Claims34
A process for forming a .gamma.-lactam carboxylic acid of Formula V:
- ##STR42## or a salt thereof, wherein R.sup.1 is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkaryl, aralkyl, where the ring portion of any of said aryl, aralkyl, or alkaryl can be optionally substituted;
- R.sup.2 is alkyl, cycloalkyl, aryl, alkaryl, aralkyl, alkoxy, hydroxy, alkoxyalkyl, or amido, where the ring portion of any of said aryl, aralkyl, or alkaryl can be optionally substituted;
- and
- said process comprising:
- (a) deprotonating a substituted aryl or heteroaryl oxazoline of Formula I:
- ##STR43## where R.sup.1 is as defined above;
- R.sup.3 is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkaryl, any of which can be optionally substituted;
- and
- R.sup.4 is aryl or heteroaryl, either of which may be optionally substituted;
- by treating said substituted aryl or heteroaryl oxazoline with a strong base to form an enolate;
- (b) transmetallating said enolate with a metal selected from the group consisting of titanium, aluminum, tin, zinc, magnesium and boron, and thereafter treating with a formyl amide of Formula XIV:
- ##STR44## where R.sup.2 is as defined above, and R.sup.5 and R.sup.6 are independently one of alkyl or alkaryl;
- or R.sup.5 and R.sup.6 when taken together with the nitrogen atom to which they are attached form a 5- to 7-membered heterocyclic ring, which may be optionally substituted, and which optionally may include an additional oxygen or nitrogen atom, to form an adduct of Formula II:
- ##STR45## where R.sup.1 through R.sup.6 are as defined above;
- c) catalytically hydrogenating said adduct of Formula II to form a .gamma.-lactam of Formula IV:
- ##STR46## where R.sup.1, R.sup.2 and R.sup.3 are as defined above;
- and d) saponifying said .gamma.-lactam of Formula IV to form a carboxylic acid of Formula V.
A compound of Formula VI or VII:
- ##STR51## or a salt thereof, wherein:
- R.sup.1 is C.sub.1-12 alkyl, C.sub.3-8 cycloalkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.6-14 aryl, C.sub.6-10 ar(C.sub.1-6)alkyl or C.sub.1-6 alk(C.sub.6-10)aryl;
- R.sup.2 is C.sub.2-6 alkyl;
- and
- R.sup.7 is alkyl, aryl, aralkyl, alkaryl, wherein any of said alkyl, aryl, aralkyl or alkaryl can be optionally substituted.
Dependencies are inferred from the claim text.